Lilly(Eli) & Company

NYSE: LLY
$807.43
-$1.02 (-0.1%)
Closing price May 24, 2024

LLY Chart and Intraday Price

LLY Company Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 743,142.26M USD
Shares Outstanding 950,164,000
Eli Lilly and Company is a global leader in pharmaceuticals, focusing on discovering, developing, and marketing a wide range of human medications. With a rich history dating back to 1876 and headquartered in Indianapolis, Indiana, it offers treatments for diabetes, including a comprehensive lineup of insulin products, and type 2 diabetes medications like Jardiance and Trulicity. The company also has a strong presence in oncology, rheumatoid arthritis, dermatology, mental health, and more, with notable products such as Alimta for cancer and Cymbalta for depression. Eli Lilly collaborates with various industry partners to enhance its product offerings.

LLY Articles

In the movie The Social Network, there’s a scene where the investor Sean Parker is trying to sweet talk Mark Zuckerberg and says “A million dollars isn’t cool… You know what’s cool?”The...
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
The exclusive trillion-dollar club currently has five American members — Apple (NASDAQ: AAPL) at around $3 trillion market capitalization, Microsoft at about $2.8 trillion, Google parent Alphabet...
Here are some of the top upgrades, downgrades and other analyst calls for Thursday, December 21, along with other investing news.
Thursday's top analyst upgrades and downgrades included Bumble, Coupang, Datadog, Dish Network, DraftKings, Eli Lilly, International Flavors & Fragrances, LivePerson, Novavax, Nvidia, Qualcomm and...
Thursday's top analyst upgrades and downgrades included Alphabet, Eli Lilly, Etsy, Microsoft, Mosaic, NetApp, Omega Healthcare Investors, RTX, Sherwin-Williams, Spotify Technology, Walt Disney and WW...
Monday's top analyst upgrades and downgrades included Amazon.com, AT&T, Broadcom, Corning, DraftKings, Eli Lilly, Fortinet, General Mills, Leslie’s, Microsoft, Nvidia, Plug Power, Progressive,...
Thursday's top analyst upgrades and downgrades included Antero Resources, AutoZone, Coterra Energy, Dollar General, Eli Lilly, First Horizon, Infosys, Owens Corning, Palo Alto Networks, Range...
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Tuesday's top analyst upgrades and downgrades included Campbell Soup, DoorDash, Eli Lilly, Enterprise Products Partners, Mastercard, Oracle, Silvergate Capital, Uber Technologies, VICI Properties,...
Wednesday's top analyst upgrades and downgrades included Amgen, Archer Daniels Midland, Eli Lilly, Home Depot, Medtronic, Palantir Technologies, Snowflake, Take-Two Interactive Software, Viatris and...
Friday morning’s analyst upgrades and downgrades included Adobe, Alcoa, Ally Financial, AppLovin, Block, Eli Lilly, Luminar Technologies, Novavax, Twilio, Wendy's, Zoom Video Communications and...
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Monday’s additional top analyst upgrades and downgrades were on American Express, Aurora Cannabis, Edison International, Eli Lilly, PayPal, Upwork and more.
J.P. Morgan takes a look at a few stocks with potentially huge upside and where they could go in light of a possible recession.